Skip to content

Study on the correlation between the expression of inflammatory factors and cognitive impairment in elderly patients undergoing hip replacement surgery with different nerve blocks under ultrasound guidance

Study on the correlation between the expression of inflammatory factors and cognitive impairment in elderly patients undergoing hip replacement surgery with different nerve blocks under ultrasound guidance

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086118
Enrollment
Unknown
Registered
2024-06-25
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative Cognitive Dysfunction

Interventions

Intravenous analgesia combined with pericapsular nerve group block analgesia group (P group):Intravenous analgesia pump combined with ultrasound-guided pericapsular nerve group block analgesia
Intravenous analgesia combined with femoral nerve block analgesia group (F group):Intravenous analgesia pump combined with ultrasound-guided femoral nerve block analgesia
Simple intravenous controlled analgesia group (Group C):Intravenous Analgesia Pumps

Sponsors

Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 65 to 90 years old, regardless of gender; 2. Body Mass Index (BMI) is between 18-30kg/m2; 3. The American Society of Anesthesiologists (ASA) classifies of patients is grades I-III. 4. Those who have not been treated with other antidepressants or anxiety medications. 5. The patient and their family members are informed and agree to the study, voluntarily sign the informed consent form and actively cooperate with the clinical study. The process of obtaining the informed consent form should comply with GCP regulations.

Exclusion criteria

Exclusion criteria: 1. ASA greater than Level III; 2. Existence of coagulation dysfunction; 3. Known allergy history to local anesthetics; 4. Puncture site rupture or infection; 5. Congenital lower limb deformities and functional impairments; 6. History of central nervous system diseases and mental illness;

Design outcomes

Primary

MeasureTime frame
Postoperative cognitive function assessment;

Secondary

MeasureTime frame
Serum levels of IL-1 ß, IL-6, IL-8, IL-10, TNF - a, CRP, and S-100 ß proteins;sleep condition;Pain assessment;Consumption of analgesic drugs;Remedial analgesia;

Countries

China

Contacts

Public ContactLiu Jie

Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine

18003370557@163.com+86 180 0337 0557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026